glutamic acid has been researched along with methylphenidate in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Carrey, N; Khan, SC; Kusumakar, V; MacMaster, FP; Sparkes, SJ | 1 |
| Carrey, NJ; Gaudet, L; MacMaster, FP; Schmidt, MH | 1 |
| Dafny, N; Swann, AC; Wanchoo, SJ | 1 |
| Howells, FM; Russell, VA; Warton, FL | 1 |
| Ana Pasquali, M; Belaus, A; Beltramo, DM; Del Carmen Montes, C; Galván, C; Velez, P; Walter Soria, N | 1 |
| Biederman, J; Hammerness, P; Henin, A; Moore, CM; Petty, C | 1 |
| Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
| Bittsansky, M; Dobrota, D; Husarova, V; Ondrejka, I | 1 |
| Barbé-Tuana, F; Biasibetti, H; Coelho, DM; de Oliveira, DL; Mussulini, BH; Parisi, MM; Pereira, MS; Pierozan, P; Rodrigues, AF; Schmitz, F; Vargas, CR; Wyse, AT | 1 |
| Calleros, OA; Campuzano, MR; Guillem, AM; Hernández-Kelly, LC; López-Bayghen, B; López-Bayghen, E; Martínez-Lozada, Z; Ortega, A | 1 |
| Cheng, J; Liu, A; Shi, MY; Yan, Z | 1 |
| Dong, H; Fan, Z; Li, W; Li, Y; Sun, X; Wang, H; Wang, P; Wu, S; Xie, R; Xiong, L; Yin, A; Zhang, J; Zhang, M; Zhu, Y | 1 |
| Gerhardt, GA; Glaser, PEA; Huettl, P; Miller, EM; Pomerleau, F; Quintero, JE | 1 |
| Dafny, N; Floren, S; Kharas, N; King, N; Thomas, M | 1 |
| Carrasco, A; Dafny, N; Floren, S; King, N | 1 |
| Chatterjee, M; Dutta, N; Mukhopadhyay, K; Saha, S; Shom, S; Sinha, S | 1 |
1 review(s) available for glutamic acid and methylphenidate
| Article | Year |
|---|---|
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
1 trial(s) available for glutamic acid and methylphenidate
| Article | Year |
|---|---|
Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Brain; Case-Control Studies; Central Nervous System Stimulants; Female; Glutamic Acid; Glutamine; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Pilot Projects; Protons; Psychiatric Status Rating Scales; Radionuclide Imaging | 2012 |
15 other study(ies) available for glutamic acid and methylphenidate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series.
Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Creatinine; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Neostriatum; Prefrontal Cortex; Propylamines; Psychiatric Status Rating Scales | 2002 |
Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Choline; Corpus Striatum; Creatine; Dose-Response Relationship, Drug; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Neural Pathways; Occipital Lobe; Phosphocreatine; Prefrontal Cortex; Reference Values | 2007 |
Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate.
Topics: Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Drug Administration Schedule; Glutamic Acid; Ibotenic Acid; Male; Methylphenidate; Motor Activity; Neural Pathways; Neurons; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Ventral Tegmental Area | 2009 |
Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
Topics: Action Potentials; Animals; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Glutamic Acid; Male; Methylphenidate; Neurons; Presynaptic Terminals; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Substantia Nigra; Synaptic Transmission; Up-Regulation; Ventral Tegmental Area | 2009 |
A simple allele-specific polymerase chain reaction method to detect the Gly143Glu polymorphism in the human carboxylesterase 1 gene: importance of genotyping for pharmacogenetic treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Antiviral Agents; Attention Deficit Disorder with Hyperactivity; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Female; Gene Frequency; Glutamic Acid; Glycine; Humans; Inactivation, Metabolic; Influenza, Human; Male; Methylphenidate; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Polymorphism, Genetic; Young Adult | 2010 |
Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aspartic Acid; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Prefrontal Cortex; Propylamines; Treatment Outcome | 2014 |
Chronic Treatment with a Clinically Relevant Dose of Methylphenidate Increases Glutamate Levels in Cerebrospinal Fluid and Impairs Glutamatergic Homeostasis in Prefrontal Cortex of Juvenile Rats.
Topics: Amino Acid Transport System X-AG; Animals; Antigens, Nuclear; Catalytic Domain; Female; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Homeostasis; Immunohistochemistry; Male; Methylphenidate; Models, Biological; Nerve Tissue Proteins; Oxidative Stress; Prefrontal Cortex; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 2016 |
Methylphenidate Increases Glutamate Uptake in Bergmann Glial Cells.
Topics: Animals; Aspartic Acid; Cell Line; Cell Membrane; Chick Embryo; Dopamine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Transporter 1; Glutamic Acid; Methylphenidate; Neuroglia; RNA; Up-Regulation | 2015 |
Disrupted Glutamatergic Transmission in Prefrontal Cortex Contributes to Behavioral Abnormality in an Animal Model of ADHD.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Glutamic Acid; Male; Methylphenidate; Prefrontal Cortex; Pyramidal Cells; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2017 |
Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.
Topics: Adaptor Proteins, Signal Transducing; Animals; Astrocytes; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Dopamine; Glutamic Acid; Humans; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Polymorphism, Single Nucleotide; Proteins; Tumor Suppressor Proteins | 2017 |
Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Electrodes, Implanted; Frontal Lobe; Glutamic Acid; Male; Methylphenidate; Movement; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Species Specificity | 2019 |
Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Caudate Nucleus; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glutamic Acid; Locomotion; Male; Methylphenidate; Motivation; Rats; Rats, Sprague-Dawley; Reward | 2019 |
Glutamate and dopamine in the VTA participate differently in the acute and chronic effect of methylphenidate.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Glutamic Acid; Locomotion; Male; Methylphenidate; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area | 2020 |
Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Genotype; Glutamic Acid; Humans; Methylphenidate; Phenotype; Receptors, Glutamate | 2023 |